Infinimmune is a new fully human antibody drug service provider that reinvents antibody discovery through an end-to-end platform to deliver antibody drugs directly from the human immune system. Infinimmune announced that it has closed a $12 million seed round led by Playground Global, with participation from Pear VC, Civilization Ventures and Axis VC, and support from Ron Alfa, Jacob Becraft, Paul Conley and Joshua Meier.
This article is transferred from: https://www.itjuzi.com/investevent/13708720
This site is only for collection, and the copyright belongs to the original author.